Yanshuo Cao

机构：Peking University, Peking University Cancer Hospital, Ministry of Education · ORCID：0000-0003-4030-8600

发表论文 74 篇 · 总被引 2046 次 · h-index 19

代表论文

• Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results (2024 · Nature Medicine · 被引 194)
• Recent developments in immunotherapy for gastrointestinal tract cancers (2024 · Journal of Hematology & Oncology · 被引 99)
• Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial (2024 · EClinicalMedicine · 被引 77)
• Helicobacter pylori and immunotherapy for gastrointestinal cancer (2024 · The Innovation · 被引 49)
• Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer (2024 · Journal for ImmunoTherapy of Cancer · 被引 35)
• A bispecific antibody–drug conjugate targeting EGFR and HER3 in metastatic esophageal squamous cell carcinoma: a phase 1b trial (2025 · Nature Medicine · 被引 19)